Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
24 September 2022
|
| In: |
Molecular therapy. Methods & clinical development
Year: 2022, Jahrgang: 27, Pages: 90-92 |
| ISSN: | 2329-0501 |
| DOI: | 10.1016/j.omtm.2022.09.003 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.omtm.2022.09.003 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S2329050122001280 
|
| Verfasserangaben: | Christine E. Engeland |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 182644713X | ||
| 003 | DE-627 | ||
| 005 | 20230426074520.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 221207s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.omtm.2022.09.003 |2 doi | |
| 035 | |a (DE-627)182644713X | ||
| 035 | |a (DE-599)KXP182644713X | ||
| 035 | |a (OCoLC)1361670250 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Engeland, Christine Elisabeth |d 1985- |e VerfasserIn |0 (DE-588)1025405951 |0 (DE-627)722221193 |0 (DE-576)370314670 |4 aut | |
| 245 | 1 | 0 | |a Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine |c Christine E. Engeland |
| 264 | 1 | |c 24 September 2022 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 07.12.2022 | ||
| 773 | 0 | 8 | |i Enthalten in |t Molecular therapy. Methods & clinical development |d New York, NY : Nature Publishing Group, 2014 |g 27(2022), Seite 90-92 |h Online-Ressource |w (DE-627)863823203 |w (DE-600)2863173-0 |w (DE-576)475381483 |x 2329-0501 |7 nnas |a Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine |
| 773 | 1 | 8 | |g volume:27 |g year:2022 |g pages:90-92 |g extent:3 |a Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.omtm.2022.09.003 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S2329050122001280 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20221207 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 1025405951 |a Engeland, Christine Elisabeth |m 1025405951:Engeland, Christine Elisabeth |d 910000 |d 910100 |d 50000 |e 910000PE1025405951 |e 910100PE1025405951 |e 50000PE1025405951 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 1 |x j |y j | ||
| 999 | |a KXP-PPN182644713X |e 422805269X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"id":{"zdb":["2863173-0"],"eki":["863823203"],"issn":["2329-0501"]},"origin":[{"publisher":"Nature Publishing Group","dateIssuedDisp":"[2014]-","publisherPlace":"New York, NY"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"partname":"Methods & clinical development","title_sort":"Molecular therapy","title":"Molecular therapy"}],"titleAlt":[{"title":"Methods and clinical development"}],"part":{"extent":"3","text":"27(2022), Seite 90-92","volume":"27","pages":"90-92","year":"2022"},"pubHistory":["1 (08. Jan. 2014)-"],"recId":"863823203","language":["eng"],"disp":"Safety study supports clinical development of immunotherapeutic oncolytic measles vaccineMolecular therapy. Methods & clinical development","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 25.06.20"]}],"physDesc":[{"extent":"3 S."}],"name":{"displayForm":["Christine E. Engeland"]},"id":{"eki":["182644713X"],"doi":["10.1016/j.omtm.2022.09.003"]},"origin":[{"dateIssuedDisp":"24 September 2022","dateIssuedKey":"2022"}],"recId":"182644713X","language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 07.12.2022"],"person":[{"role":"aut","display":"Engeland, Christine Elisabeth","roleDisplay":"VerfasserIn","given":"Christine Elisabeth","family":"Engeland"}],"title":[{"title_sort":"Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine","title":"Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine"}]} | ||
| SRT | |a ENGELANDCHSAFETYSTUD2420 | ||